Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics

Lindahl Anna; Heuchel Rainer; Forshed JennyLehtio JanneLohr MatthiasNordstrom Anders

首页> 外文期刊>Metabolomics : >Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics

【24h】

Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics

机译：Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Introduction Pancreatic ductal adenocarcinoma (PDAC) is the fifth most common cause of cancer-related death in Europe with a 5-year survival rate of <5. Chronic pancreatitis (CP) is a risk factor for PDAC development, but in the majority of cases malignancy is discovered too late for curative treatment. There is at present no reliable diagnostic marker for PDAC available.

著录项

来源
《Metabolomics :》 |2017年第5期|art. no. 61-art. no. 61|共10页
作者
Lindahl Anna; Heuchel Rainer; Forshed JennyLehtio JanneLohr MatthiasNordstrom Anders;
展开▼
作者单位

Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden;

Karolinska Inst, Dept Clin Sci Intervent & Technol, CLINTEC, Stockholm, Sweden;

Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类生理学;
关键词
Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pancreatitis; Metabolomics; Metabolism; LC-MS; Biomarkers; Serum; Plasma; Discovery; Validation;

Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics

摘要

著录项

相关主题

期刊订阅